Inventaire - your friends and communities are your best library - Inventaire

Claudin-1 as a promoter of EMT in hepatocellular carcinoma.

author

Georgios Giamas

published in: Oncogene

date of publication: 2013-01-14

language: English

Cites articles 11

Date

Title

Authors

2012-07-02

ENTPD1/CD39 is a promising therapeutic target in oncology
2012-05-29

Claudin-2 promotes breast cancer liver metastasis by facilitating tumor cell interactions with hepatocytes

Atilla Ömeroğlu, Eitan Amir, Mark Clemons
2012-03-01

Targeted therapy for hepatocellular carcinoma: novel agents on the horizon

Giuseppe Montalto, Melchiorre Cervello, Antonella Cusimano, Antonina Azzolina
2012-07-01

Proof of concept for claudin-targeted drug development
2012-11-19

Claudin-1 induces epithelial-mesenchymal transition through activation of the c-Abl-ERK signaling pathway in human liver cells

Myung Chan Gye
2010-07-08

Claudin family of proteins and cancer: an overview
2010-05-13

Claudin 1 in breast tumorigenesis: revelation of a possible novel "claudin high" subset of breast cancers
2009-11-06

Claudin-1 acts through c-Abl-protein kinase Cdelta (PKCdelta) signaling and has a causal role in the acquisition of invasive capacity in human liver cells
2008-11-01

Systemic therapy of hepatocellular carcinoma: are we making progress?

T. R. Jeffry Evans, Patricia Roxburgh
2005-11-01

Claudin proteins in human cancer: promising new targets for diagnosis and therapy
2005-06-16

Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer

Article - wd:Q44446426

Welcome to Inventaire

the library of your friends and communities

you are offline